Cytokinetics
CYTK
CYTK
109 hedge funds and large institutions have $187M invested in Cytokinetics in 2016 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 39 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% less capital invested
Capital invested by funds: $276M → $187M (-$89.1M)
52% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 31
Holders
109
Holding in Top 10
3
Calls
$4.27M
Puts
$1.2M
Top Buyers
| 1 | +$11.8M | |
| 2 | +$10M | |
| 3 | +$4.47M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.41M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.31M |
Top Sellers
| 1 | -$3.95M | |
| 2 | -$3.87M | |
| 3 | -$3.65M | |
| 4 |
Renaissance Technologies
New York
|
-$2.36M |
| 5 |
Millennium Management
New York
|
-$1.96M |